Adhera Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adhera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
  • Adhera Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$269K, a 50.8% increase year-over-year.
  • Adhera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$1.28M, a 12.3% increase year-over-year.
  • Adhera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$1.62M, a 140% decline from 2021.
  • Adhera Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$674K, a 66.9% increase from 2020.
  • Adhera Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$2.04M, a 82% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.